Safety study of IMM-H014 in healthy adults
Treatments studied
Part of Digestive system clinical trials.
This trial tests a new drug called IMM-H014 in healthy volunteers to see if it is safe and how the body processes it. It also checks if food changes how the drug works. You may join if you are generally healthy and meet the age and weight requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female
- Your body mass index (BMI) is between 18 and 28
- You are willing to use effective birth control for 6 months after the study
- You have no major health conditions like heart, liver, kidney, or stomach problems
- You have not taken any prescription or over-the-counter meds, herbs, or supplements in the last 2 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called IMM-H014 for people with MASH, a type of fatty liver disease. The drug aims to reduce liver fat and improve liver health, and this trial will check its safety and effects.
This study tests an experimental medication called XTYW007 to see if it is safe and how it works in the body. You would take the pills under close supervision and have your health monitored.
This trial tests a new drug called HP515 for people with non-alcoholic fatty liver disease, including NASH or MASH. It aims to see if the drug can help reduce liver fat and improve liver health.
This early-stage study checks if a new medicine called HEC169584 is safe for people and how it moves through the body. It looks for healthy volunteers to take part.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new medicine, HSK31679, for people with MASH (a type of fatty liver disease with inflammation and scarring). It aims to see if the drug can help improve liver health.
Hear when a new Nonalcoholic Steatohepatitis (NASH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.